Vol.
93, No.
April
29,
4, 1980
BIOCHEMICAL
AND
BIOPHYSICAL
RESEARCH
COMMUNICATIONS Pages
1980
INFLUENCE
OF PROSTAGLANDINS
METABOLISM
AND OF CYCLIC
OF 25-HYDROXYVITAMIN
D3 IN PRIMARY
Trechsel,
CHICK
KIDNEY
Carol M. Taylor, Jean-Philippe and Herbert Fleisch
CELL
Bonjour
Department of Pathophysiology, University of Murtenstrasse 35, 3010 Berne, Switzerland Received February
ON THE
1
CULTURE Ulrich
NUCLEOTIDES
1210-1216
Berne,
20, 1980
SUMMARY Prostaglandins (PG) are likely to be involved in a number of regulatory mechanisms in the kidney, which may be mediated by cyclic nucleotides. The present study describes the effects of prostaglandins and cyclic nucleotides on the hydroxylases of 25-hydroxycholecalciferol (25(OH)D3) in a primary chick kidney cell culture. 3-30 nM PG E produced significant increases in the 25(OH)D -lhydroxylase issociated with decreases in the 25(OH)D3-24-hyJroxylase at 6 hours but not at 1 hour. in concentrations between 0.3 nM and 3 PM affected the in a similar manner. A significant increase of l-hydroxylase activity was observed with 0.1 mM cyclic AMP (CAMP) or dibutyryl cyclic AMP (dbcAMP) in 6 hours, but again no effect on either hydroxylase was observed when the incubation time was reduced to 1 hour. These results suggest that PG E2 and PG F might be involved in the regulation of renal 25(OH)D metabolisiN and that the effects on the 25(OH)D3hydroxylases mig ;i t be mediatkd by CAMP. INTRODUCTION The kidney
is
D3 (25(OH)D3) active (7,8).
form
the
site
to
dihydroxyvitamin
of can
vitamin also
conversion
suggestions
as to
in the 3 be metabolized
(11,12)
but
defined
no well
the
of
25-hydroxyvitamin
D3 (l,25(OH)2D3),
D
D3 (24,25(OH)2D3)
several
1
of
1,25-dihydroxyvitamin
known
25(OH)D3
(1,2,3,4)
intestine in
(9,lO).
function
This work has been supported by the Foundation (3.725.76), F. Hoffmann-La Switzerland, and by the AusbildungsArbeitsgemeinschaft fiir Osteosynthese
has
(5,6)
the
kidney
There
physiological
role yet
the
been
have of
most
and
in
bone
to
24,25-
been
this
metabolite
discovered.
Swiss National Science Roche & Co. AG, Basel, und Forderungsfonds der (AO), Chur, Switzerland.
Vol. 93, No. 4, 1980
BIOCHEMICAL AND BLOPHYSICAL RESEARCH COMMUNICATIONS
The development tories of
of
kidney
(13,14,15,16)
long-term
has
mechanisms In a previous
chick
cell
to
hormone the
(PTH)
and
are
in
suggesting
that
alternative
to
ases In
under the
in
increased
the
study vitro study and of
in primary
chick
in
and many of suggested
to
a number the
with kidney
the
for
we have
In
investigation
of
this
a primary 3H-25(OH)D3
system
reduced
1,25W-U2D3
obtained culture of
in
4 hours.
in
vivo
represents the
parathyroid
and reduced
24-hydroxylase
regulation
25(OH)D3
described
-l-hydroxylase
results
labora-
of metabolizing
6 hours.
cell
the
regulation
capable
25(OH)D3
activity
(PG)
involved
the
chick
the
(15)
by several
tool
3H-24,25(OH)2D3.
agreement
present
glandins ases
in
in
system
stimulated
1-hydroxylase
systems
a new
report
and to
24-hydroxylase
effects
provided
culture
3H-l,25(OH)2D3
culture
involved
metabolism. kidney
cell
renal
the These
(17,18,19), a useful
25(0H)D3-hydroxyl-
conditions. we have cyclic
physiological
be mediated
the
nucleotides
kidney of
investigated
cell
on the
culture.
regulatory
by cyclic
of
these
nucleotides
of
prosta-
25(0H)D3-hydroxyl-
PG are
mechanisms
effects
effects
in
thought the
to be
kidney
compounds
(20) have
been
(21).
METHODS AND MATERIALS __The cell cultures were produced and the 25(0H)D3 hydroxylases assayed as described previously (15). Briefly, kidneys of 10 day old chicks were digested with collagenase and hyaluronidase; the 6 cells were cultured in Petri dishes, 3.5 cm in diameter, 1.2 x 10 cells, in 1.5 ml of minimum essential medium (MEM) with Earle's The medium salt solution, antibiotics and 10 % fetal calf serum. contained 1.2 mM Ca. 2 x 250 pmoles of 25(OH)D3 were added 24 Cultures were kept in a humidified and 48 hours after p&ating. C02-incubator, at 37 C. Confluence was obtained 3 days after PG and cyclic nucleotides were addded to confluent culplating. Control dishes received tures in 15 ~1 EtOH or distilled water. 15 1~1 solvent. Incubation with the agents was terminated by refetal calf serum and placing the medium by 1 ml of MEM without The cultures were incubated with without PG or syclic nucleotide. 100 pmolles of The reaction was stopped H-25!OH)D3 for 30 min. with methanol, tritiated vitamin D3 metabolites were extracted on small-particle silica into chloroformjmethanol and separated
1211
Vol.
93, No.
BIOCHEMICAL
4, 1980
AND
BIOPHYSICAL
RESEARCH
COMMUNICATIONS
The eluent chromatography (HPLC). high pre ssure liquid Results are expressed in n-hexane. consisted of 1 2.5 % isopropanol recovered from the HPLC. as the percent age of the radioactivity using
25(OH)[26,27-3B]D3 (specific activity 7.3 Ci/mmol) was obtained Synthetic 25(OH)D from the Radiochemical Centre, Amersham, U.K. a. was kindly donated by Hoffmann-La Roche fi Co., Basel, Switzerlan AMP (CAMP), dibutyryl cyclic AMP (dbcAMP) and PG E PG F2u, cyclic dibu r yryl cyclic GMB (dbcGMB) were from Sigma Chemical Co., St. medium, antibiotics and Louis, MO, USA. Eagle's minimum essential fetal calf serum were from Gibco, Paisley PA3 4EP, Renfrewshire, Scotland, U.K. Collagenase (type I) and hyaluronidase (type I) were Organic solvents and all other chemicals from Sigma Chemical Co. were analytical grade. RESULTS Effect
25(0H)D3-hydroxylases. associated tained that
Figure
of prostaqlandins:
with
with
a decrease
incubation
of
the
3 nM PG E2 in 6 hours.
that
shows the effect
A significant
30 nM PG E2 produced
demonstrates
1
were not
observed
Separate
when the
0.001
Fig.
I-hydroxylase was ob-
experiments (not
showed Figure
shown).
incubation
6 hours
of
time was reduced
2 24.25 1 hour
Values
the activity
of PG E2 seen after
:
Fig.
of
24-hydroxylase
effects
maximum
the effects
increase
of PG E2 on the
1.25
24.25 6 hours
1.25
Effect of PG E (6 hours) on the metabolism of 3H-25(OH)D3 cell culture in primary chi .e k kidney l p < 0.05; l * p < 0.01; *** p < are means + SEM, n = 3. by Student's t-test for unpaired values.
1:
2: Evidence for a delayed hydroxylases to PG E Values are means + SEM, n = 3. unpaired values. -
response **
1212
of
p < 0.01
the
renal
by Student's
25(OH)D3t-test
for
2
Vol.
93, No.
4, 1980
BIOCHEMICAL
AND
PGF>,
BIOPHYSICAL
RESEARCH
COMMUNICATIONS
(nM)
Fig.
3: Effect of PG F (6 hours) on the metabolism of 3H-25(OH)D3 in primary chi$? kidney cell culture Values are means + SEM, n = 4. ** p < 0.01 by Student's t-test for unpaired values. to
one hour.
PG F2u,
Similarly
and 3 b!M,. produced under
idential
Effect
of
produced
of
the
hydroxyl3se. hour
did
(Fig.
up to 1
not
of
24-hydroxylase
concentratior,s
in
? mM failed
mM CAMP added
influence
(Fig.
As shown
increase
the
to
between
in hydroxylase
conditions
nucleotides:
a significant
concentrations
changes
experimental
cyclic
a decrease in
significant
in
nM
activities
3).
in Table
the
0.3
I,
CAMP and dbcAMP
25(0H)D3-1-hydroxylase
6 hours. to
In
produce
confluent
contrast
any
effect
cultures
25iOH)D3-hydroxylase
for
and dbcGMP on either only
1
activities
4J.
DISCUSSION Our
rescits
of
the
of
agent.s,
been
renal
shown
sugqest
that
PG E 2 and PG F2,L
25(0H)D3-hydroxylases suc9
as bradykinin,
to modulate
renal
at
the
noradrenalin PG synthesis
1213
act
may
tissue
as modulators level.
and vasopressin (22).
It
is
A number have therefore
Vol.
93, No.
4, 1980
Table
BIOCHEMICAL
Effect of cyclic in kidney cell
I:
AND
BIOPHYSICAL
nucleotides
on
RESEARCH
COMMUNICATIONS
of 3H-25(OH)03
metabolism
culture % conversion
Cyclic
Concentration
nucleotide
3H-24,25(0H)2D3 __ __.._______
(mM)
CAMP (Exp. 1)
0
2.6 + 0.2 2.5 + 0.2 1.8 T- 0.2
0.1 1
dbcAMP (Exp. II)
3.9 3.4 2.5 2.3
0
0.01
0.1 1
dbcGMP (Exp. II)
n = 3.
0
Values
Student's conceivable
metabolism.
As
to
the
might
of
action
of
of
10
evidence
of
m+lmM
: : ”
act
s
2 0
lllrir
I 24.25 lhour
Fig.
1.25
*
p
c
factors
‘T 0.1
**
T __ 0.4 **
by
which
at
the
regulate in renal
cellular
.:-: .: ::: :.: :_ :j: ::: _‘. a:.: -_
been
accumulated
are
Especiaily
suggesting
involved
those
.::. . 1:: :: !!.I-
24.25 Ghours
*
+ 0.4 T 0.2
Q.ifl
alterations
interactions
CAMP
:: ::: ::: .I. ::: ::: :.:
l
prostaglandins
prostaglandins.
6
::_: :::: :::: :::: :.:.
0.05;
through
has
*
l
+ 0.2 5.1 -T 0.3 5.6 T 0.2 5. 7 7-. 0.1
T 0.2 T - 0.2 p ”
l
s . ‘7
+ 0.1
8
4
**
+ 0.3
: .- VI c
0.1
4.7 5.7 6.7 7.6
+- 0.2 **
nucleotide
effects
z ::
T
OH) 2D3
6.7 t 0 1 8.0 T 0 2 8.5 -T 0 3
*
physiological
vivo
amount
cellular
the
l
values.
in
prostaglandin-cyclic
several
+ SEM.
unpaTred
of
mechanism
a large
means
some
metabolism
PG
that
for
that
25(OH)D3
level,
are
t-test
3H-1,25 - _----.- ~--_-- -
+ 0.2 T 0.2
3.8 4.0 4.2 4.0
0.01 0.1 1
to
1.25
4: Evidence for a delayed response of the renal 25(OH)D3hydroxylases to CAMP Values are means + SEM, n = 4. l * p < 0.01; **‘* p .. 0.001 by Student's t-test Tar unpaired values.
in
of
Vol.
93, No.
the
.4, 1980
BIOCHEMICAL
E-series
number
have
of
been
systems
of
kidney
cell
culture
tained
in
of
results
lend
senger
the
hydroxylase
already
Further
work in
25(OH)D3
is
the
in
a
play
effect Thus
this
that
is
enzyme
elevating
modulation
study of
whether
the
second
that
CAMP.
PTH and PG E2 in
mes-
25(OH)D3-lPTH,
PG E2
Furthermore tubules
suggests
CAMP levels
prostaglandins
stimulatory
of
an increase
renal
conceivable through
the
PG E2 and PG F2a
to be the
kidney
to
in
stimulator
through
isolated
needed
a
ob-
in vitro
a role
of PTH on the
it
with
findings
as
hypothesis
suggested
in
tubules
metabolism
been
obtained
between
kidney
25(0H)D3-l-hydroxylase
(23,24,25).
interaction
earlier
CAMP might
to the
stimulatory
evidence
a role
that
support
and PG F2e stimulate recent
cyclase
25(0H)D3-hydroxylases with
isolated
25(OH)D3
CAMP has
for
COMMUNICATIONS
adenylate
on the
renal
the
stimulate
CAMP.
RESEARCH
stimulate
agreement
and with
the
Our
in
in
suggested
1 -hydroxylase.
might
are
(23)
which
the
to
CAMP and dbcAMP
vivo
regulation
shown
BIOPHYSICAL
(21).
The effects
(24,251,
AND
effect
(26).
might of
an
play
PTH on the
-1-hydroxylase.
ACKNOWLEDGEMENTS We thank Miss A. Monod, J. Portenier, C. Steiner and M. Tschannen for their skilled technical assistance, Mrs. C. Stieger for assisof tance in illustration, and Mrs. B. Gyger for the preparation the manuscript. REFERENCES 1. Omdahl, 2. Norman,
J.L., A.W.,
and DeLuca, H.F. (1974) and H. Henry
(1973)
Physiol.Rev. 53, Recent Prog. Horm.Res.
327-372. 30,
431-480.
3. Fraser, 4. De:Luca,
D.R. H.F.,
Proc.Nutr.Soc. 34, 139-143. H.K.(1976) Ann.Rev.Biochem. and Schnoes,
(1975)
45,
631-666.
5. Bo,yle, H.F.
I.T., (1972)
Miravet, L., Endocrinology
Gray, R.W., 90, 605-608.
121.5
Holick,
M.F.,
and DeLuca,
Vol.
93, No.
6.
4, 1980
BIOCHEMICAL
AND
BIOPHYSICAL
RESEARCH
COMMUNICATIONS
Wong,
R.G., Norman, A.W., Ready, C.R., and Coburn, J.W. J.Clin.Invest. 51, 1287-1291. Raisz, L.G., Trummel, C.L., Holick, M.F., and DeLuca H.F. (1972) Science 175, 768-769. Reynolds, J.J., Holick, M.F., and DeLuca, H.F. (1973) Calcif. Tiss.Res.12, 295-301. Holick, M.F., Schnoes, H.K., DeLuca, H.F., Gray, R.W., Boyle, and Suda, T. (1972) Biochemistry 11, 4251-4255. I.T., Taylor, C.M., Mawer, E.B., Wallace, J.E., St. John, J., Cochran, M., Russell, R.G.G., and Kanis, J.A. (1978) Clin.Sci. Molec.Med. 55, 541-547. Norman, A.W., and Henry, H.L. (1979) Vitamin D, Basic Research and Its Clinical Application, pp. 571-578, de Gruyter, Berlin. Kanis, J.A., Cundy, J., Bartlett, M., Smith, R., Heynen, G., Warner, G.J., and Russell, R.G.G. (1978) Brit.Med.J. 1, 1382(1972)
7. 8. 9. 10.
11. 12.
1386. 13. 14. 15. 16. 17. 18.
Juan, D., and DeLuca, H.F. (1977) Endocrinology 101, 1184-1193. (1979) J.Biol.Chem. 254, 2722-2729. Henry, H.L. Trechsel, U., Bonjour, J.-P., and Fleisch, H. (1979) J.Clin. Invest. 64, 206-217. Spanos, E., Barrett, D.I., Chonq, K.T., and MacIntyre, I. (1978) Bi0chem.J. 174, 231-236. Garabedian, M., Holick, M.F., DeLuca, H.F., and Boyle, I.T. (1972) Proc.Natl.Acad.Sci.USA 69, 1673-1676. Fraser, D.R., and Kodicek, E. (1973) Nature (Lond.)New Biol. 241,
19.
20. 21.
163-166.
Tanaka, Y., Lorenc, R.C., and DeLuca, H.F. (1975) Arch.Biochem. Biophys. 171, 521-526. Dunn, M.J., and Hood, V.L. (1977) Am.J.Physiol. 233, F169-F184. Samuelsson, B., Goldyne, M., Grandstrom, E., Hamberg, M., Hammarstrom, S., and Malmsten, C. (1978) Ann.Rev.Biochem. 47, 997-1029.
22. 23. 24. 25.
26.
Danon, A., Chang, L.C., Sweetman, S.J., Nies, A.S., and Oates, (1975) Biochim.Biophys.Acta 388, 71-83. J.A., Horiuchi, N., Suda, T., Takahashi, H., Shimazawa, E., and Ogata, E. (1977) Endocrinology 101, 969-974. Rasmussen, H., Wong, M., Bikle, D., and Goodman, D.B.P. (1972) J.Clin.Invest. 51, 2502-2504. Larkins, R.G., MacAuley, S.J., Rapoport, A. Rapoport, Martin, T.J., Tulloch, B.R., Byfield, P.G.H., Matthews, E.W., and Clin.Sci.Molec.Med. 46, 569-582. MacIntyre, I. (1974) Biddulph, D.M., Currie, M.G., and Wrenn, R.W. (1979) Endocrinology 104, 1164-1171.
1216